P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sa... (gs Information ...)

HOME >> MEDICINE >> NEWS

P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth

Date:10/29/2008

gs Information

Three Months Ended September 30, 2008

Earn-

%Change ings %Change %Change

Versus Before Versus Net Versus

Net Year Income Year Earn- Year

Sales Ago Taxes Ago ings Ago

Beauty $5,128 12% $983 11% $754 9%

Grooming 2,142 6% 645 5% 478 6%

Beauty GBU 7,270 10% 1,628 9% 1,232 8%

Health Care 3,700 4% 990 1% 658 2%

Snacks, Coffee and Pet Care 1,229 9% 194 5% 120 6%

Health and Well-Being GBU 4,929 5% 1,184 2% 778 2%

Fabric Care and Home Care 6,510 10% 1,268 -6% 831 -9%

Baby Care and Family Care 3,772 10% 807 19% 514 20%

Household Care GBU 10,282 10% 2,075 2% 1,345 0%

Total Business Segments 22,481 9% 4,887 4% 3,355 3%

Corporate (455) N/A (204) N/A (7) N/A

Total Company 22,026 9% 4,683 10% 3,348 9%

JULY - SEPTEMBER NET SALES

INFORMATION

(Percent Change vs. Year Ago) *

Volume Volume

With Without Net

Acquisitions/ Foreign Mix/ Sales

Divestitures Exchange Price Other Growth

Beauty GBU

Beauty
'/>"/>

SOURCE The Procter & Gamble Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related medicine news :

1. Cardinal Health Reports First Quarter Results
2. uKarma Reports Progress With International Distribution Agreement for Its Xflowsion DVD Series
3. STAAR Surgical Reports 33% Third Quarter Revenue Growth
4. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
5. Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008
6. LCA-Vision Reports Third Quarter 2008 Financial Results
7. Universal Health Services, Inc. Reports 2008 Third Quarter Results
8. PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results
9. Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009
10. WellPoint Reports Third Quarter 2008 Results
11. Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80

Post Your Comments:

(Date:1/8/2009)...CAGO, Jan. 8 Allscripts-...ipts Healthcare Solutions, Inc. (Allscripts or,th...for the three and six,months ended November 30, 2...in/prnh/20061005/ALLSCRIPTSLOGO-b ) , The C...d November 30, 2008,include results from legacy A...

(Date:1/8/2009)...TON, Jan. 8 The Pew Cha...has been named director, chemical and food safety ...y program. Olson, who was formerly deputy staff di... on Environment and Public Works, brings nearly 25...onsumer advocacy to Pew. , , "We are excited t...

(Date:1/8/2009)...une Promoted to Principal. Christine Siu and Jaso...INNEAPOLIS, SAN FRANCISCO and STAMFORD, Conn., Jan...s, a health care venture capital firm that invests... today announced the promotion of three members of...d to Principal. Christine Siu and Jason Brown hav...

(Date:1/8/2009)...POLIS, Jan. 8 A proposa...diers and Sailors Children,s Home has prompted the...ana to revamp its annual Mid-Winter conference Jan...ate its members, nearly unanimous opposition to th...ides more than $50,000 in direct and in-kind suppo...

[0] Allscripts Reports Fiscal 2009 Second Quarter Results [0] Veteran Environmental Health Expert Erik D. Olson to Join Pew [0] Thomas, McNerney & Partners Promotes Three Members of Its Investment Team [0] Indiana American Legion to Organize, Launch Opposition to Closing of Children's Home

...ers in a recent study on both mice and humans are ...to their body than others. Did you know that if yo..., say, //or a doughnut - the amount of cholesterol... Experts know that high cholesterol is linked to h...

...study are trying to observe why surgery may trigg...re ongoing. It's long been known that some older p...l functions after an operation// - a condition kno....Often relatives will say that the person has 'nev...

...ers it is observed that a drug already being used ...fective male contraceptive. Researchers hypothesiz...een approved in Europe to treat Gaucher's disease,...affects the metabolism of sugar-fat compounds esse...

...y, a protein in the eye has prevented and stopped ...earchers say this could lead to promising treatmen...e sclerosis and type 1 diabetes. Scientists from t...Boston found the factor alpha-MSH can be harnessed...

Other Medicine News:

Discovering cholesterol-absorbing genes Memory deprivation after operations A new male contraceptive Protein in eye fights diseases

(Date:1/6/2009)...ts from prior U.S., U.K. and China Trials , , S...Inc. (VTI), a development stage company targeting ...has begun for a randomized, controlled, multi-cent...racorporeal Liver Assist Device (ELAD) as a treatm...der three protocols. The study is open for enrollm...

(Date:1/6/2009)...e/ -- Cequent Pharmaceuticals, a pioneer in the de...treatments to prevent and treat human disease, ann...uccessful toxicology study of its candidate CEQ501...eting the primary oncogene (beta-catenin, CTNNB1) ... inherited gastrointestinal disease that causes hu...

(Date:1/5/2009)...swire/ -- Women undergoing in vitro,fertilization...port early,pregnancy, but the intramuscular injec...inful for patients. Formulations of progesterone ...ous injection or vaginal suppository may offer,si... With patient well-being a constant focus, Fert...

(Date:12/27/2008)...ewswire/ -- According to the latest,science, resv...est doses of,resveratrol plus an array of antioxi...asses of aged, red wine, rather than resveratrol a...i-bin/prnh/20080603/LATU039 ) , The most r...s to prolong,the life of laboratory mice. In fac...

Breaking Medicine Technology:ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2 ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3 Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2 Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3 Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2 Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2 Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3 IMTEC Introduces the SPRITE CT System 21584 1 IMTEC Introduces the SPRITE CT System 21584 2 HMS Holdings Corp to Present at Jefferies 2nd Annual Healthcare Conference 21582 1 COSE Introduces Health Incentives Wellness Programs for Medium Size Businesses 21580 1 COSE Introduces Health Incentives Wellness Programs for Medium Size Businesses 21580 2 Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 1 Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 2 Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 3 Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 4 Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 5

[0] ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers [2] Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference [2] Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF [2] Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone

...gression-free survival in,the SPARC Phase 3 trial ...isk of disease progression for patients receiving,...e use,geographies, as well as presence or absence...tCall/ -- Pharmion,Corporation and GPC Biotech AG ...a from the double-blind, randomized satraplatin Ph...

...ts EORTC 40983 (EPOC),Intergroup Study Results, CH...ults of the,randomized phase III EORTC 40983 Inter...rst time that peri-operative (pre and post,surgery...combination with a standard chemotherapy regimen f...V)) given to patients with,resectable liver metast...

Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer

The herbal extracts, vitamins, minerals, and antioxidants in this formula increases circulation to ocular tissue, improves tear quality, and maintains healthy function of the lens and retina of the e

...-Rads QCNet is the industry-leading portal to QC i... easy and rapid way to access their quality contro...ternet. UnityWeb enables Bio-Rad customers to acce...boratory Reports, as well as convenient online dat...

The ACCU-CHEK Spirit insulin pump system offers frequent and precise delivery of the basal rate and rapid infusion of the bolus. The ACCU-CHEK Spirit pump is safe, reliable and easy to program.

The MiniMed Paradigm REAL-Time System is the world's first system to integrate an insulin pump with REAL-Time continuous glucose monitoring, taking diabetes management to a level you just can't achie

Medicine Products:

TheraLife Dry Eye Enhanced®QCNet ACCU-CHEK Spirit Insulin Pump System Paradigm® REAL-Time Insulin Pump and Continuous Glucose Monitoring System

P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sa...(gs Information ...),Health